Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
28.99
+1.02 (3.65%)
Apr 29, 2026, 1:24 PM CST
86.07% (1Y)
| Market Cap | 11.35B |
| Revenue (ttm) | 704.16M |
| Net Income (ttm) | 22.26M |
| Shares Out | 405.71M |
| EPS (ttm) | 0.05 |
| PE Ratio | 509.78 |
| Forward PE | 155.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,010,210 |
| Average Volume | 7,922,818 |
| Open | 27.69 |
| Previous Close | 27.97 |
| Day's Range | 27.47 - 29.17 |
| 52-Week Range | 14.93 - 34.68 |
| Beta | 0.39 |
| RSI | 44.63 |
| Earnings Date | Mar 31, 2026 |